TriangleNCT04756401 · OUTCOME
Effect of Immunomodulatory Imide Drug-14 Scores Gene Expression Profile (GEP) on Progression-Free Survival
This outcome was registered, but no numerical results were posted in the captured record.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- Baseline up to progression-free survival, assessed up to 5 years
What was measured
The progression free survival (PFS) is defined as the time from registration to the earliest date of documentation of disease progression or death due to any cause. Patients will be categorized by their GEP and progression-free survival estimates will be compared across GEP scores.
Groups in this outcome
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denom Units Selected
- Participants
- description
- The progression free survival (PFS) is defined as the time from registration to the earliest date of documentation of disease progression or death due to any cause. Patients will be categorized by their GEP and progression-free survival estimates will be compared across GEP scores.
- reporting Status
- NOT_POSTED
- time Frame
- Baseline up to progression-free survival, assessed up to 5 years
- title
- Effect of Immunomodulatory Imide Drug-14 Scores Gene Expression Profile (GEP) on Progression-Free Survival
- type
- OTHER_PRE_SPECIFIED
Download exact source JSON → · Snapshot ctgov-results-d643ffaf417bcef6d45eb5e0
Preserved source evidence · Not medical advice